| Esophageal and Gastroesophageal Junction Carcinoma studied in …STUDIED_INderived200 of 1,309show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06203600Phase 2/Phase 3 · recruiting Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07212491enrolling by invitation Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529808Phase 1/Phase 2 · recruiting Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07603375Phase 2 · recruiting Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03030404completed Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Hereditary Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05965999recruiting Lucid Registry Study · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392892Phase 2/Phase 3 · recruiting Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07733180Phase 2 · recruiting A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06005493Phase 1/Phase 2 · recruiting Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05152147Phase 3 · active not recruiting A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06123338Phase 2 · recruiting A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07757906NA · active not recruiting Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253650Phase 2 · recruiting Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836049Phase 2 · not yet recruiting PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835087NA · recruiting Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04295811NA · active not recruiting Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06329869Phase 2 · recruiting Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830355Phase 2 · not yet recruiting Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With Residual Tumor and Positive Lymph Nodes · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03776487Phase 2 · active not recruiting Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07147361active not recruiting Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05043688Phase 3 · active not recruiting Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC. · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06780111Phase 1/Phase 2 · recruiting Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109726Phase 1/Phase 2 · recruiting A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07405151Phase 1/Phase 2 · recruiting A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F) · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06324357Phase 1/Phase 2 · recruiting Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07751341Phase 2 · recruiting A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822906not yet recruiting Risk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and Surgery · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823270Phase 2 · not yet recruiting Neoadjuvant Sacituzumab Tirumotecan Plus Toripalimab in Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06687603NA · recruiting Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730373Phase 2 · recruiting First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07429487NA · recruiting Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04111172Phase 2 · suspended A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248452Phase 3 · active not recruiting Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04543617Phase 3 · completed A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04921904Phase 1/Phase 2 · completed Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482516Phase 3 · recruiting Evaluating Novel Therapies in ctDNA Positive GI Cancers · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799274Phase 1 · active not recruiting Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06732388Phase 2 · recruiting Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07615374NA · recruiting Laparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818018Phase 1/Phase 2 · recruiting A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818070Phase 3 · not yet recruiting A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02521285Phase 2 · active not recruiting Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140500Phase 1/Phase 2 · active not recruiting Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05365581Phase 1 · recruiting A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05753748NA · recruiting Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764875Phase 3 · recruiting A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673887Phase 3 · recruiting A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714538recruiting Breath Research Narrow Validation for Gastrointestinal Cancer Detection · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01142388Phase 2 · active not recruiting Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04661150Phase 2 · completed A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111626Phase 3 · terminated Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06266299Phase 1 · recruiting A Study of KK2269 in Adult Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07000253Phase 2 · recruiting Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07811752Phase 2 · recruiting Sacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02962063Phase 1/Phase 2 · active not recruiting Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05715931Phase 2 · active not recruiting Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07431281Phase 3 · recruiting Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07282912Phase 2 · recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07807956Phase 1 · not yet recruiting A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01366144Phase 1 · active not recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04391049Phase 1 · active not recruiting Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04704661Phase 1 · active not recruiting Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06364410Phase 1 · recruiting Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07090499Phase 1 · recruiting A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05677490Phase 3 · recruiting mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07602842Phase 1/Phase 2 · recruiting A Study of IDP-001 in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07801027Phase 4 · not yet recruiting A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803159not yet recruiting Frailty, Immunonutrition, Surgery Type, and Biologic Recovery in Elderly Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05319730Phase 1/Phase 2 · recruiting A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334069recruiting Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995898NA · recruiting The Vanguard Study: Testing a New Way to Screen for Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07283939NA · recruiting Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07799077Phase 2 · not yet recruiting Paclitaxel Polymeric Micelles and Cisplatin Plus Sintilimab as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07799649not yet recruiting ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04209686Phase 2 · completed Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05945823Phase 2 · active not recruiting Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06881043recruiting The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07486518recruiting A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07795749Phase 2 · recruiting Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796113Phase 2 · recruiting Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06414733Phase 1 · recruiting HER-2 B Cell Peptide Vaccine · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544589Phase 1 · recruiting A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791329Phase 2 · completed Sequential FDG-PET and miRNA as Biomarkers of Preoperative Treatment Strategy in LA Oesophago-Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03615326Phase 3 · completed Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07700667Phase 2 · recruiting SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07787273Phase 2 · recruiting Interferon Gamma Plus Camrelizumab as Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594626Phase 1/Phase 2 · recruiting BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780968not yet recruiting Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01882933Phase 3 · completed D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03801876Phase 3 · active not recruiting Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Thoracic Esophagus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084481Phase 1 · recruiting Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554521Phase 2 · recruiting A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781319completed Early Gastric Cancer in the Spanish EURECCA Registry · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04147494early Phase 1 · active not recruiting Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04535401Phase 1 · active not recruiting Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04949256Phase 3 · terminated Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014). · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06250036Phase 2 · suspended Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788548NA · recruiting Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer（IDEAL Stage 2b） · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581405Phase 2 · not yet recruiting GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778056not yet recruiting Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05203627NA · active not recruiting Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07001748Phase 2/Phase 3 · recruiting Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06846996recruiting Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07182149Phase 1 · recruiting A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222657Phase 2 · recruiting Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769658not yet recruiting Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769866NA · not yet recruiting Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04221893NA · recruiting Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038098Phase 1 · not yet recruiting Magnetic Sentinel Lymph Node Mapping in Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522336Phase 1 · completed Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399757Phase 1/Phase 2 · active not recruiting A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06549413terminated 18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488624completed Survival Prediction After Neoadjuvant Chemoimmunotherapy and Esophagectomy for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04939051Phase 2 · recruiting Obeticholic Acid for Prevention in Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06242470Phase 1 · recruiting A Study of MGC026 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06596954NA · recruiting Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792435Phase 1/Phase 2 · active not recruiting XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05713838Phase 2 · active not recruiting Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07751055Phase 2 · recruiting Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07596654recruiting The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021066Phase 1 · active not recruiting Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07699939Phase 2 · recruiting Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07747688recruiting Retrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06644781Phase 3 · recruiting A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745322active not recruiting Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06281886Phase 2 · completed Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04460937Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Distal Esophagus Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07629817Phase 3 · recruiting Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641313Phase 2 · active not recruiting Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06914687Phase 2 · active not recruiting Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615013Phase 1 · recruiting NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Cervical Esophagus Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476796Phase 2 · active not recruiting Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07724496recruiting Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A Real-World Observational Study · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05028725NA · recruiting Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06304974Phase 3 · active not recruiting A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04210115Phase 3 · completed Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05208762Phase 1 · recruiting A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06131840Phase 1 · recruiting A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06157892Phase 2 · active not recruiting A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06243757active not recruiting A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07721103Phase 2 · not yet recruiting Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164979Phase 2 · completed Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522320active not recruiting Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05078047Phase 3 · active not recruiting Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07709767Phase 2 · not yet recruiting Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07711470Phase 2 · active not recruiting Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04523818Phase 1 · active not recruiting Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04607590NA · active not recruiting Yoga Program for Improving the Quality of Life in Couples Coping With Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05041153early Phase 1 · active not recruiting Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05705492Phase 2 · recruiting Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07464756Phase 2 · recruiting SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07487896Phase 3 · recruiting A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554456Phase 2/Phase 3 · recruiting A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02) · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686926Phase 2 · not yet recruiting Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanced Esophageal Squamous Cell Carcinoma, Phase II · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705412completed Postoperative Radiotherapy and Lymph Node Dissection After Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03712566active not recruiting Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07701681Phase 2 · not yet recruiting Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07702253active not recruiting O-GlcNAcylation Induced HMGB1 Signalling · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04840264Phase 2 · recruiting Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06490003recruiting Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07697859recruiting PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07697898not yet recruiting TDLN-Guided Lymphadenectomy After Neoadjuvant Immunochemotherapy for ESCC · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07699185Phase 2 · recruiting Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07697040Phase 1 · not yet recruiting Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03114319Phase 1 · terminated Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689292Phase 2 · not yet recruiting Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07692477not yet recruiting Molecular Characterization of Tumor-Microenvironment Interactions to Predict Drug Resistance in Gastric and GEJ Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06585488Phase 1 · terminated A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification · condition mapped CURATED_BROADER · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518147Phase 3 · recruiting A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689851Phase 2 · recruiting Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06165380Phase 2 · active not recruiting Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06824363early Phase 1 · recruiting ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu · condition mapped ALIAS · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224750recruiting A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07403136Phase 2 · recruiting Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621484Phase 2 · not yet recruiting HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07688291Phase 2 · not yet recruiting A Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based Chemotherapy · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04389632Phase 1 · recruiting A Study of Sigvotatug Vedotin in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07685704Phase 2 · not yet recruiting Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05709574Phase 2 · active not recruiting Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07682376Phase 2 · active not recruiting Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05530343NA · recruiting Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05802056Phase 1 · active not recruiting Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836584Phase 2 · active not recruiting Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07139951Phase 2 · enrolling by invitation Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07678580Phase 2 · not yet recruiting Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276791NA · recruiting EMR Versus ESD for Barrett's Neoplasia · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Barrett Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06747585Phase 1/Phase 2 · recruiting A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07206589NA · not yet recruiting Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial · condition mapped ONTOLOGY_EXACT · 1,309 trials mapped (550 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |